Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AMRI and Ono Broaden SMARTSOURCING™ Collaboration

Published: Friday, April 26, 2013
Last Updated: Friday, April 26, 2013
Bookmark and Share
New agreement extends drug discovery and development collaboration between the companies.

AMRI has announced that it has entered into a new five-year service agreement with Ono Pharmaceutical Company, Ltd., (TSE: 4528), a pharmaceutical company headquartered in Osaka, Japan.

Under the terms of the agreement, AMRI may provide a range of services from early drug discovery to cGMP manufacturing.

The two companies have already agreed to medicinal chemistry projects within the new framework to collaborate on additional hit-to-lead and lead optimization for two new molecules, with the work to take place at AMRI’s medicinal chemistry laboratories in Albany, N.Y.

An early adopter of the AMRI SMARTSOURCING™ concept, Ono has been utilizing AMRI’s integrated global facilities and capabilities for projects ranging from early drug discovery, including high-throughput screening (HTS), biology support and computer-aided drug discovery (CADD), to multiple medicinal chemistry programs and a variety of drug development and cGMP programs.

Thomas E. D’Ambra, Ph.D., Chairman, President and CEO of AMRI said, “We are pleased to extend and broaden our service agreement with Ono. During the past few years, Ono has become a very important client for AMRI and we would like to acknowledge the deepening relationship between our companies. Our project management teams and the scientists on all the Ono projects, from Singapore to the United States, enjoy working with our counterparts at Ono and they are a valuable customer and partner.”

Louis Garguilo, Vice President of Business Development, said, “SMARTSOURCING™ is an industry leading movement to strategic decision making and the true measurement of results and success in drug discovery, development and manufacturing. Over the years, our relationship with Ono has grown based on this type of value-added collaboration. We are also happy to announce this expanding relationship in conjunction with the 2013 Biotechnology Industry Organization (BIO) International Convention in Chicago, at the one-year anniversary of our re-branding launch of AMRI SMARTSOURCING™ at this very show last year in Boston.”

Kazuhito Kawabata, Ph.D., Member of the Board of Directors, Executive Officer and Executive Director, Discovery and Research of Ono, said, “We appreciate AMRI’s integrated capabilities and global reach, and believe that they are the partner of choice to mutually work toward the best decisions and outcomes for many of our projects. We look forward to continuing our relationship across the drug discovery and development areas.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AMRI To Acquire Aptuit Drug Product Development Businesses
Significantly expands AMRI's analytical services capabilities and extends drug product development services to include sterile injectable formulation development.
Friday, January 09, 2015
AMRI Announces Senior Level Leadership Appointment
The appointment of Michael A. Luther, Ph.D. as Senior Vice President of Discovery sees AMRI expanding its biology capabilities.
Thursday, October 17, 2013
AMRI Further Expands Discovery Capabilities in India
Two strategic hires bring additional flexibility to global drug discovery operations.
Thursday, June 21, 2012
AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
Agreement demonstrates AMRI’s commitment to value creation from its proprietary portfolio of compounds and programs.
Friday, April 06, 2012
Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
AMRI to receive a $750,000 milestone payment from licensing agreement.
Wednesday, November 11, 2009
Scientific News
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Simplifying Gene Testing Access for Ovarian Cancer Patients
Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
New Skin Cancer Drugs with Surprising Powers
Inserm team synthesizes and developed new drugs for melanoma.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!